PDS Biotechnology Corporation (PDSB) Stock price, Description, News & Info

#Thinksabio latest news

PDS Biotech Announces Presentation of Preliminary Results from Phase 2 Study of IL-12 Tumor Targeted Immunocytokine (PDS01ADC) in 3rd Line Metastatic Castration Resistant Prostate Cancer by the NCI